Find Reports
Select Report Type
Reimbursement Review
Displaying 1401 - 1413 of 1413
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| tarlatamab | Imdelltra | tarlatamab | Extensive stage small cell lung cancer | Active | PC0351-000 | ||||
| belantamab mafodotin, bortezom... | TBC | belantamab mafodotin, bortezomib, dexamethasone | Previously treated multiple myeloma | Active | PC0379-000 | ||||
| ferric carboxymaltose | Ferinject | ferric carboxymaltose | Iron deficiency in adult patients with heart failure | Active | SR0852-000 | ||||
| inavolisib | Itovebi | inavolisib | Advanced or metastatic breast cancer | Active | PC0382-000 | ||||
| darolutamide | Nubeqa | darolutamide | Metastatic castration-sensitive prostate cancer | Pending | PC0404-000 | ||||
| NSCLC without actionable oncog... | Non-small Cell Lung Cancer | Merged | PH0059-000 | ||||||
| Non-small Cell Lung Cancer | Non-small Cell Lung Cancer | Merged | PH0081-000 | ||||||
| omaveloxolone | Skyclarys | omaveloxolone | Friedreich’s ataxia | Active | SR0864-000 | ||||
| nemolizumab | TBC | nemolizumab | atopic dermatitis | Active | SR0869-000 | ||||
| mirikizumab | Omvoh | mirikizumab | Crohn’s disease | Received | SR0880-000 | ||||
| guselkumab | Tremfya | guselkumab | Crohn’s disease | Active | SR0882-000 | ||||
| tofersen | Qalsody | tofersen | Amyotrophic lateral sclerosis (ALS) | Received | SR0883-000 | ||||
| odevixibat | Bylvay | odevixibat | Alagille syndrome | Received | SR0884-000 |
Health Technology Review
Displaying 576 - 596 of 596
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 30 of 30
View All Reports
Displaying 1401 - 1425 of 2119
Please scroll or swipe to the right to view the full content.